<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03804294</url>
  </required_header>
  <id_info>
    <org_study_id>Vitamin D and ART</org_study_id>
    <nct_id>NCT03804294</nct_id>
  </id_info>
  <brief_title>Effect of Vitamin D on Outcome of Assisted Reproductive Technology(ART);</brief_title>
  <acronym>ART</acronym>
  <official_title>Effect of Vitamin D on Outcome of Assisted Reproductive Technology(ART)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitamin D has many biological functions. Vitamin D receptors are widely distributed in the&#xD;
      male and female reproductive system. Animal experiments have shown that vitamin D deficiency&#xD;
      can affect hormone synthesis and gamete formation, reduce sperm motility, and may be related&#xD;
      to diseases such as PCOS and endometriosis. Population studies suggest that vitamin D may be&#xD;
      related to androgen levels and sperm quality, but whether vitamin D affects the outcome of&#xD;
      assisted reproduction is controversial and inconclusive. This study intends to explore&#xD;
      whether vitamin D affects the outcome of assisted reproduction through a large sample cohort&#xD;
      study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vitamin D plays an important role in reproduction, while there is high prevalence of vitamin&#xD;
      D deficiency. Serum 25(OH)D was categorized according to clinically accepted ranges for&#xD;
      vitamin D deﬁciency (&lt;20 ng/mL), insufﬁciency (20-30 ng/mL), and replete (&gt;30 ng/mL).&#xD;
&#xD;
      This is a retrospective cohort study of about 2000 infertile couples who undergo their ﬁrst&#xD;
      IVF/ICSI and IUI cycle at Reproductive Medicine Center of Peking University Third Hospital.&#xD;
      Patients will be excluded if they refuse to be recruited. Serum samples are collected the day&#xD;
      when patients first time to Reproductive Medicine Center and were stored at -20℃ until&#xD;
      assayed. Life style of patients is collected by questionair. Vitamin D status is measured by&#xD;
      assessing circulating levels of 25(OH)D in frozen, never previously thawed serum samples&#xD;
      using radioimmunoassay.&#xD;
&#xD;
      The investigators will comapere the ART outcomes in different groups according to serum&#xD;
      25(OH)D status.&#xD;
&#xD;
      In female, the primary outcome is clinical pregnancy rates deﬁned as the presence of an&#xD;
      intrauterinesac with an embryonic pole demonstrating cardiacactivity at 7 weeks of gestation.&#xD;
      Secondary outcomes are quality of embryo, positive hCG rates and live birth rates.&#xD;
&#xD;
      In male, the primary outcome is semen quality, such as semen volume, sperm concentration,&#xD;
      sperm motility, morphologically normal percent and progressive motile spermatozoa percent.&#xD;
      Secondary outcomes are clinical pregnancy rates and live birth rates.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">November 28, 2018</start_date>
  <completion_date type="Anticipated">July 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>clinical pregnancy rates</measure>
    <time_frame>12 weeks after transplantation</time_frame>
    <description>Time Frame:&#xD;
the presence of an intrauterinesac with an embryonic pole demonstrating cardiacactivity</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>ART</condition>
  <arm_group>
    <arm_group_label>vitamin D-ART</arm_group_label>
    <description>Infertile couples who undergo their ﬁrst IVF/ICSI and IUI cycle in Reproductive Medicin Center of Peking university Third Hosiptal.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        infertile couples&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        infertile couples who undergo their ﬁrst IVF/ICSI and IUI cycle at Reproductive Medicine&#xD;
        Center of Peking University Third Hospital.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        refusing to be recruited.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>XU ZHI</last_name>
    <role>Study Chair</role>
    <affiliation>Peking University Third Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>XU ZHI, doctor</last_name>
    <phone>01082266757</phone>
    <phone_ext>01082266757</phone_ext>
    <email>zhixujp@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>yilu chen, bachelor</last_name>
    <phone>8601082266752</phone>
    <phone_ext>01082266757</phone_ext>
    <email>yilua_chen@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking University Third Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100091</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>XU ZHI</last_name>
      <phone>01082266757</phone>
      <email>zhixujp@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>January 11, 2019</study_first_submitted>
  <study_first_submitted_qc>January 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 15, 2019</study_first_posted>
  <last_update_submitted>January 15, 2019</last_update_submitted>
  <last_update_submitted_qc>January 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University Third Hospital</investigator_affiliation>
    <investigator_full_name>Zhi Xu</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

